ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006

In Brief: New Presidents Take Office At ONS, ONCC, ARS; Baird Wins Awards; New VP In Houston

July 8, 1994

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

First Test Of Cooperative Groups’ Willingness To Change Coming In New Colorectal Trials

November 14, 1986